𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive performance and Parkinson disease: Neuropsychological and CT study

✍ Scribed by D. Pauletto; V. Toso

Publisher
Springer Milan
Year
1987
Tongue
English
Weight
279 KB
Volume
8
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuropsychological correlates of brain a
Neuropsychological correlates of brain atrophy in Parkinson's disease: A CT-scan study
✍ Dr. Sergio E. Starkstein; RamΓ³n Leiguarda πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 459 KB

## Abstract We examined the presence of cortical or subcortical brain atrophy (as shown by CT scans) in patients with Parkinson's disease (PD) and assessed whether there were significant correlations between CT measurements and the presence of cognitive deficits. There were three main findings. Fir

Cognitive dysfunction and dementia in Pa
Cognitive dysfunction and dementia in Parkinson disease
✍ Nuria Caballol; Maria J MartΓ­; Eduardo Tolosa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

Impairment in different cognitive domains such as executive functions, language, memory, and visuospatial skills occurs frequently in Parkinson disease (PD) even in the early stages of the disease. Although frank dementia (Parkinson disease dementia, PDD) is less frequent, risk for developing dement

Pentagon drawing and neuropsychological
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia
✍ Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J. TovΓ©e πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio

Parkinson's disease/Parkinson syndromesβ€”
Parkinson's disease/Parkinson syndromesβ€”Cognitive functions
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

We have measured increment thresholds for a 4.1 cycfdeg grating in 24 de-novo patients (Hoehn and Yahr stage I to 111) with idiopathic (IPS) and 9 patients with nonidiopathic parkinson syndrome (N-IPS) and for comparison 26 age-matched normal controls. Patients with positive L-Dopa and apomorphine